Cargando…
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arsenal of drugs available for treatment. The existing drugs have significant deficiencies so there is an urgent need for new and improved drugs. In the human host, Leishmania are obligate intracellular p...
Autores principales: | Nühs, Andrea, De Rycker, Manu, Manthri, Sujatha, Comer, Eamon, Scherer, Christina A., Schreiber, Stuart L., Ioset, Jean-Robert, Gray, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583543/ https://www.ncbi.nlm.nih.gov/pubmed/26407168 http://dx.doi.org/10.1371/journal.pntd.0004094 |
Ejemplares similares
-
Chemical Validation of Methionyl-tRNA Synthetase as
a Druggable Target in Leishmania donovani
por: Torrie, Leah S., et al.
Publicado: (2017) -
Thymoquinone Induced Leishmanicidal Effect via Programmed
Cell Death in Leishmania donovani
por: Islamuddin, Mohammad, et al.
Publicado: (2022) -
Pharmacological Validation of N-Myristoyltransferase
as a Drug Target in Leishmania donovani
por: Corpas-Lopez, Victoriano, et al.
Publicado: (2018) -
Screening Novel Vaccine Candidates for Leishmania Donovani by Combining Differential Proteomics and Immunoinformatics Analysis
por: Zhang, Jianhui, et al.
Publicado: (2022) -
The Q(i) Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani
por: Wall, Richard J., et al.
Publicado: (2020)